-
1دورية أكاديمية
المصدر: International Journal of Infectious Diseases, Vol 104, Iss , Pp 474-478 (2021)
مصطلحات موضوعية: Antibiotic stewardship, Electronic monitoring, Antibiotic usage, Infectious and parasitic diseases, RC109-216
وصف الملف: electronic resource
-
2
المؤلفون: Frederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, Anna Christine Nilsson, Christian Nielsen, Dorte K Holm, Kamilla Østergaard, Mathilde Vilhelmine Miller Hvidt, Keld-Erik Byg, Isik S Johansen, Kristen Mittl, William Rowles, Scott S Zamvil, Riley Bove, Joseph J Sabatino, Tobias Sejbaek
المصدر: Journal of Neurology, Neurosurgery & Psychiatry. :jnnp-2022
مصطلحات موضوعية: Psychiatry and Mental health, Surgery, Neurology (clinical)
-
3
المؤلفون: Hamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, Christian Nielsen, Dorte K. Holm, Kamilla Østergaard, Agnes Hauschultz Witt, Keld-Erik Byg, Isik S. Johansen, Kristen Mittl, William Rowles, Scott S. Zamvil, Riley Bove, Joseph J. Sabatino, Tobias Sejbaek
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c0eb04c3f91b2e93570a2ce636fa1088
https://doi.org/10.1101/2022.01.27.22269944 -
4
المؤلفون: Hamza Mahmood Bajwa, Frederik Novak, Anna Christine Nilsson, Christian Nielsen, Dorte K. Holm, Kamilla Østergaard, Agnes Hauschultz Witt, Keld-Erik Byg, Isik S. Johansen, Kristen Mittl, William Rowles, Scott S. Zamvil, Riley Bove, Joseph J. Sabatino, Tobias Sejbaek
المصدر: Bajwa, H M, Novak, F, Nilsson, A C, Nielsen, C, Holm, D K, Østergaard, K, Witt, A H, Byg, K E, Johansen, I S, Mittl, K, Rowles, W, Zamvil, S S, Bove, R, Sabatino, J J & Sejbaek, T 2022, ' Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients ', Multiple Sclerosis and Related Disorders, vol. 60, 103729 . https://doi.org/10.1016/j.msard.2022.103729
مصطلحات موضوعية: Multiple Sclerosis, COVID-19 Vaccines, Mononuclear, Messenger, CD8-Positive T-Lymphocytes, Antibodies, Viral, Autoimmune Disease, Antibodies, Anti-CD20, Vaccine Related, Clinical Research, Booster vaccine, Leukocytes, Humans, CD20, RNA, Messenger, Viral, Longitudinal Studies, Prospective Studies, Ocrelizumab, Antigens, Lung, BNT162 Vaccine, Immunity, Cellular, SARS-CoV-2, Prevention, Vaccination, Immunity, Neurosciences, COVID-19, General Medicine, Antigens, CD20, mRNA vaccine, Infectious Diseases, Good Health and Well Being, Neurology, Antibody response, Leukocytes, Mononuclear, RNA, BNT162b2, Immunization, Cellular, Neurology (clinical), Infection
وصف الملف: application/pdf
-
5
المؤلفون: Tobias Sejbaek, Anna Bystrup, Frederik Novak, William Rowles, Kira Mcpolin, Sharon A. Sagan, Michael R. Wilson, Christian Nielsen, Joseph J. Sabatino, Kristen Mittl, Kamilla Østergaard, Anna Nilsson, Isik Somuncu Johansen, Chloe Gerungan, Scott S. Zamvil, Riley Bove, Keld-Erik Byg, Collin M. Spencer, Dorte Kinggaard Holm
المصدر: Novak, F, Nilsson, A C, Nielsen, C, Holm, D K, Østergaard, K, Bystrup, A, Byg, K E, Johansen, I S, Mittl, K, Rowles, W, Mcpolin, K, Spencer, C, Sagan, S, Gerungan, C, Wilson, M R, Zamvil, S S, Bove, R, Sabatino, J J & Sejbaek, T 2021, ' Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis ', Multiple Sclerosis and Related Disorders, vol. 56, 103251 . https://doi.org/10.1016/j.msard.2021.103251
Multiple Sclerosis and Related Disordersمصطلحات موضوعية: Messenger, Booster dose, Antibodies, Viral, Immunoglobulin G, Clinical trials, Viral, Ocrelizumab, Anti-cd20, Lung, biology, Immunogenicity, Vaccination, Humoral, General Medicine, Infectious Diseases, Neurology, 5.1 Pharmaceuticals, Pneumonia & Influenza, Development of treatments and therapeutic interventions, Infection, Covid-19, Biotechnology, medicine.drug, Multiple Sclerosis, COVID-19 Vaccines, medicine.drug_class, Sars-cov-2, Vaccine Efficacy, Monoclonal antibody, Autoimmune Disease, Article, Antibodies, Vaccine Related, Immune system, Clinical Research, Biodefense, medicine, Humans, RNA, Messenger, BNT162 Vaccine, SARS-CoV-2, business.industry, Prevention, Immunity, Neurosciences, COVID-19, Pneumonia, Immunity, Humoral, Good Health and Well Being, Emerging Infectious Diseases, Concomitant, Immunology, biology.protein, RNA, Immunization, Neurology (clinical), business
وصف الملف: application/pdf
-
6
المؤلفون: Frederik Novak, Ostergaard, K., Munksgaard Berg, J., Hilt Kristensen, C., Zsolt Illes, Sellebjerg, F., Tobias Sejbaek
المصدر: University of Southern Denmark
Novak, F, Ostergaard, K, Berg, J M, Kristensen, C H, Illes, Z, Sellebjerg, F & Sejbaek, T 2021, ' Extended dosage interval of B-cell therapy in multiple sclerosis ', Multiple Sclerosis Journal, vol. 27, no. Suppl. 2, pp. 767 . < https://doi.org/10.1177/13524585211047080 >
Novak, F, Østergaard, K, Berg, J M, Kristensen, C H, Illes, Z, Sellebjerg, F & Sejbaek, T 2021, ' Extended dosage interval of B-cell therapy in multiple sclerosis ', Multiple Sclerosis Journal, vol. 27, no. Suppl. 2, P941, pp. 767 . https://doi.org/10.1177/13524585211047080URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::86c1d22b9f7ba0b9068c18a2ecfe5758
https://portal.findresearcher.sdu.dk/en/publications/f0219333-aa58-4bcb-bb9d-2a2d4154e39f